中文摘要：

通过人胚胎干细胞（human embryonic stem cells，hESC）体外分化方法和畸胎瘤形成可以分化获得多种成体细胞．但目前尚不清楚是否可以从hESCs畸胎瘤中分离某些特异性细胞．通过体外筛选方法，有效地从hESCs畸胎瘤中分离出神经前体细胞（neural progenitor cells，NVCs）和间充质干细胞（mesenchymal stem cells，MSCs）．这种hESCs畸胎瘤来源的NPCs和MSCs与体内神经前体细胞和间充质干细胞有着相似的分子标记和特性，并具有进一步的分化潜能——分别可以诱导成为神经元、神经胶质细胞、脂肪细胞和骨骼细胞等．根据人胚胎干细胞畸胎瘤中含有不同分化阶段的外胚层、中胚层和内胚层的组织或细胞，认为人胚胎干细胞畸胎瘤可以作为另一个细胞来源以获取多种（包括人胚胎干细胞体外分化难以得到的）各种前体／干细胞和终末分化细胞．

英文摘要：

Many somatic cell types were obtained by in vitro differentiation or teratoma formation of human embryonic stem cells （hESCs）. However, it is unclear whether specific cell types can be obtained from hESCs-derived teratoma. It was reported that many kinds of cells, including neural progenitor/precursor cells （NPCs） and mesenchymal stem cells （MSCs） were isolated efficiently from the teratoma of hESCs through in vitro selection. The teratoma-derived NPCs and MSCs showed specific characteristics of molecular markers similar to the primary NPCs and MSCs. Moreover, these teratoma-induced NPCs and MSCs can be further induced to differentiate into neurons, astrocytes, or adipose and bone cells, reflecting their inherent multi-potencies. Given that teratoma normally contains a mixture of ectoderm, mesoderm, and endoderm lineage ceils at different differentiation stage, it was suggested that hESCs-derived teratoma could be an alternative source to generate a variety of uncommitted progenitor cells or terminally differentiated somatic cells, which may be otherwise difficult to obtain through direct in vitro differentiation.